SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-043582
Filing Date
2015-05-18
Accepted
2015-05-18 11:21:59
Documents
2
Period of Report
2015-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2187
2 POA DOCUMENT poa.txt EX-24.3_583021 3534
  Complete submission text file 0001209191-15-043582.txt   7125
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 284 WALTHAM MA 02451
Business Address
Laghrissi-Thode Fouzia (Reporting) CIK: 0001642015 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36517 | Film No.: 15872253